Trademark Overview
On Friday, April 24, 2020, a trademark application was filed for EPSILOGEN with the United States Patent and Trademark Office. The USPTO has given the EPSILOGEN trademark a serial number of 88885762. The federal status of this trademark filing is REGISTERED as of Tuesday, October 5, 2021. This trademark is owned by Epsilogen Ltd. The EPSILOGEN trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceutical drugs for suppressing tumors; pharmaceutical drugs for treating malignant tumors; pharmaceutical drugs for the treatment of cancer; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for treating malignant tumors; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; anti-cancer drugs; anti-cancer preparations; anti-cancer preparations of plant origin; anti-cancer preparations of chemical origin; compounds for treating cancer; tumor suppressing agents; immunostimulants; medicine for suppressing tumors; medicine for treating malignant tumors; medicine for the treatment of cancer; diagnostic reagents for medical laboratory use
Scientific and technological services, namely, scientific research in the field of pharmaceutical research and development and research and design relating thereto; pharmaceutical drug development services; pharmaceutical research and development; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals; clinical research in the field of cancer treatment; clinical trials for others; conducting clinical trials for others in the field of pharmaceutical products; providing medical and scientific research information about the results of clinical trials for pharmaceutical products; scientific research for medical purposes in the area of cancerous diseases; research and development services of technology in the fields of oncology, immunology and immuno-oncology
Medical treatment services of cancerous diseases; medical screening of cancerous diseases; medical diagnostic monitoring, testing, and analysis services; medical services, namely, diagnosis and treatment of cancerous diseases; pharmaceutical services, namely, dispensing pharmaceuticals; pharmaceutical services, namely, pharmaceutical consultation; pharmaceutical services, namely, pharmaceutical compounding services; pharmaceutical advisory services; laboratory analysis services relating to the treatment of persons by medical laboratories; laboratory analysis services relating to the diagnosis and treatment of cancerous diseases by medical laboratories; providing cancer screening services; medical analysis services for cancer diagnosis and prognosis; RNA or DNA analysis for cancer diagnosis and prognosis by medical laboratories; medical services in the field of oncology, immunology and immuno-oncology; providing advice relating to oncology, immunology and immuno-oncology; providing on-l...
